Intra‐arterial chemotherapy for retinoblastoma. Challenges of a prospective study

Abstract

Our study reports the activity and reproducibility of IAM in advanced retinoblastoma but also underlines the challenges of performing prospective studies on this treatment modality. Toxicity was limited to only ocular vascular events.